This inventor holds 6 USPTO granted patents and 2 published patent applications. Top assignees: Merck Frosst Canada, Inc., Merck Frosst Canada & Co., Merck + Co., Inc.. Active years: 1995-2007.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:


Years Active: 1995-2007
Title: Gary P O'Neill: Innovator in Cyclooxygenase Research
Introduction
Gary P O'Neill is a notable inventor based in Dollard des Ormeaux, Canada. He has made significant contributions to the field of biochemistry, particularly in the study of cyclooxygenases. With a total of 6 patents to his name, O'Neill's work has advanced the understanding of cyclooxygenase-2 and its implications in various biological processes.
Latest Patents
O'Neill's latest patents include groundbreaking inventions such as the "Human cyclooxygenase-2 cDNA and assays for evaluating cyclooxygenase-2 activity." This invention discloses a human cyclooxygenase-2 cDNA, along with assays designed to measure cyclooxygenase-2 or cyclooxygenase-1 activity in a given sample. Another significant patent is "High level expression of human cyclooxygenase-2," which details methods for increasing the expression of human cyclooxygenase-2 in transformed cells and assays for measuring cyclooxygenase-2 in samples.
Career Highlights
Throughout his career, Gary P O'Neill has worked with prominent companies such as Merck Frosst Canada, Inc. and Merck Frosst Canada & Co. His experience in these organizations has allowed him to collaborate on various innovative projects that have contributed to advancements in medical research.
Collaborations
O'Neill has collaborated with esteemed colleagues, including Joseph A Mancini and Philip J Vickers. These partnerships have fostered a collaborative environment that has led to significant advancements in their respective fields.
Conclusion
Gary P O'Neill's contributions to the field of cyclooxygenase research are noteworthy. His innovative patents and collaborations have had a lasting impact on biochemistry and medical research.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile